Project Details
Description
A Phase 1B / 2 Open-Label Study to Investigate the Safety, Tolerance and Efficacy of Drug Resistance Immunotherapy with Activated Gene Modified allogeneic or Autologous Gamma Delta; T Cells (DELTEX) inCombination with Maintenance Temozolomide in Subjects
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/22 → 10/4/24 |
Funding
- IN8BIO, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.